This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Horne, B. D. Articles by Anderson, J. L. Search for Related Content PubMed PubMed Citation Articles by Horne, B. D. Articles by Anderson, J. L.

Statin therapy, lipid levels, C-reactive protein and the survival of patients with angiographically severe coronary artery disease

^a Cardiovascular Department, LDS Hospital, Salt Lake City, Utah, USA
^b University of Utah, Salt Lake City, Utah, USA

View larger version (20K): [in a new window]   Figure 1 Kaplan-Meier survival curve showing the cumulative survival according to statin prescription. In contrast with the findings of the 4S trial, the curve separation occurred between 30 and 40 days after statin prescription. Solid line = statins; dashed line = no statins.

View larger version (16K): [in a new window]   Figure 2 Percent mortality for statin prescription stratified by CRP levels. For patients receiving statins the risk due to increasing CRP was eliminated. In contrast, among those not prescribed statins, a significant trend toward higher mortality existed across increasing CRP tertiles. CRP = C-reactive protein.